Spruce Biosciences, Inc.

NasdaqCM:SPRB Stock Report

Market Cap: US$20.3m

Spruce Biosciences Management

Management criteria checks 3/4

Spruce Biosciences' CEO is Javier Szwarcberg, appointed in Jan 2022, has a tenure of 2.83 years. total yearly compensation is $2.16M, comprised of 26.9% salary and 73.1% bonuses, including company stock and options. directly owns 0.26% of the company’s shares, worth $52.65K. The average tenure of the management team and the board of directors is 2.8 years and 4.8 years respectively.

Key information

Javier Szwarcberg

Chief executive officer

US$2.2m

Total compensation

CEO salary percentage26.9%
CEO tenure2.8yrs
CEO ownership0.3%
Management average tenure2.8yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

Insufficient Growth At Spruce Biosciences, Inc. (NASDAQ:SPRB) Hampers Share Price

May 29
Insufficient Growth At Spruce Biosciences, Inc. (NASDAQ:SPRB) Hampers Share Price

Is Spruce Biosciences, Inc. (NASDAQ:SPRB) Popular Amongst Institutions?

Jan 12
Is Spruce Biosciences, Inc. (NASDAQ:SPRB) Popular Amongst Institutions?

Spruce Biosciences outlines milestones for 2021

Jan 06

CEO Compensation Analysis

How has Javier Szwarcberg's remuneration changed compared to Spruce Biosciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$39m

Jun 30 2024n/an/a

-US$43m

Mar 31 2024n/an/a

-US$47m

Dec 31 2023US$2mUS$580k

-US$48m

Sep 30 2023n/an/a

-US$49m

Jun 30 2023n/an/a

-US$48m

Mar 31 2023n/an/a

-US$47m

Dec 31 2022US$4mUS$540k

-US$46m

Compensation vs Market: Javier's total compensation ($USD2.16M) is above average for companies of similar size in the US market ($USD651.40K).

Compensation vs Earnings: Javier's compensation has been consistent with company performance over the past year.


CEO

Javier Szwarcberg (54 yo)

2.8yrs

Tenure

US$2,157,418

Compensation

Dr. Javier Szwarcberg, M.D., M.P.H., is CEO & Director of Spruce Biosciences, Inc. from January 2022. Dr. Szwarcberg is an accomplished physician executive with many years of leadership experience in the b...


Leadership Team

NamePositionTenureCompensationOwnership
Michael Grey
Executive Chairman7.6yrsUS$119.39k0%
$ 0
Javier Szwarcberg
CEO & Director2.8yrsUS$2.16m0.26%
$ 52.7k
Samir Gharib
President & CFO4.5yrsUS$1.20m0.49%
$ 99.5k
Ralph Charlton
Chief Medical Officer2.7yrsUS$1.00m0.13%
$ 27.2k
P. Ramtin
Senior Vice President of Business Operations2.3yrsno datano data
Heidi Petersen
Senior Vice President of Regulatory & Quality1.3yrsno datano data

2.8yrs

Average Tenure

54yo

Average Age

Experienced Management: SPRB's management team is considered experienced (2.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Michael Grey
Executive Chairman7.6yrsUS$119.39k0%
$ 0
Javier Szwarcberg
CEO & Director2.8yrsUS$2.16m0.26%
$ 52.7k
Daniel Spiegelman
Independent Director4.2yrsUS$106.89k0%
$ 0
Tiba Aynechi
Independent Director8.5yrsUS$99.39k0%
$ 0
Percival Barretto-Ko
Independent Director1.5yrsUS$127.84k0%
$ 0
Balaji Muralidhar
Independent Director4.8yrsUS$94.39k0%
$ 0
Camilla Simpson
Independent Director7.1yrsUS$98.39k0%
$ 0

4.8yrs

Average Tenure

53yo

Average Age

Experienced Board: SPRB's board of directors are considered experienced (4.8 years average tenure).